CEACAM5 and carcinoma of esophagus: In the present study, decreased tumour-related antigen (CEA and SCC) and malignant biomarkers (IL-6 and MIC-1) expression at both mRNA and protein secretion levels in CMSP-treated cells indicated that oesophageal cancer cells lost the malignant phenotype gradually.